コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 , and Vesicle-Associated Membrane Protein 2 (VAMP2).
2 2 and 3, but at a novel site (Arg66-Ala67 in VAMP2).
3 ) and vesicle-associated membrane protein 2 (VAMP2).
4 osis, vesicle-associated membrane protein 2 (VAMP2).
5 in of vesicle-associated membrane protein 2 (VAMP2).
6 of a soluble SNARE coil domain derived from VAMP2.
7 P-25 heterodimers were able to interact with VAMP2.
8 SNARE regions to the fusogenic complex with VAMP2.
9 es containing syntaxin1A, but not SNAP-25 or VAMP2.
10 ampus, but females expressed lower levels of VAMP2.
11 of 200 kDa (FIP200), as a binding partner of VAMP2.
12 Munc18-1 and 2 SNARE proteins-syntaxin 1 and VAMP2.
13 complexes containing syntaxin4, SNAP23, and VAMP2.
14 addition, septin 7 coimmunoprecipitates with VAMP2.
15 as not able to interact with synaptobrevin-2/VAMP2.
16 otein and compared the relative abundance of VAMP2/3 in JG cells versus total mouse kidney mRNA by qu
18 Overall, our results show that functional VAMP2/3 in OL lineage cells is essential for proper myel
19 age of the vesicle associated SNARE proteins VAMP2/3 in the OL lineage of both male and female mice i
21 igodendrocyte surface proteins revealed that VAMP2/3 incorporates axon-myelin adhesion proteins that
23 In the developing mouse spinal cord, many VAMP2/3-cleaved OLs appeared to stall in the premyelinat
24 Through live imaging, we discovered that VAMP2/3-mediated exocytosis drives membrane expansion wi
27 on of vesicle-associated membrane protein 2 (VAMP2)-a component of the SNARE complex that resides on
29 C2b with YES kinase and increased content of VAMP2, a protein on insulin secretory granules, at the p
30 n the final maturation of many peptides, and VAMP2, a vesicle soluble N-ethylmaleimide-sensitive fact
31 hat helix 12 provides a folding template for VAMP2, accelerating SNAREpin assembly and membrane fusio
35 n VAMP8 knock-out (-/-) acini confirmed that VAMP2 and -8 are the primary VAMPs for regulated exocyto
37 vesicle-associated membrane proteins (VAMP), VAMP2 and -8, each controlling 50% of stimulated secreti
41 Condensate formation is specific for R-SNARE VAMP2 and dependent on alphaSYN lipid membrane binding.
43 we used tetanus toxin to chronically cleave VAMP2 and inhibit SNARE-mediated neurotransmitter releas
45 of two endogenous axonal membrane proteins, VAMP2 and NgCAM, in order to elucidate the cellular even
46 f endogenous fluorescent labeled presynaptic VAMP2 and postsynaptic PSD95 in long-term cultured live
47 y of SNAP-25 to interact with syntaxin 1 and VAMP2 and prevents the assembly of the SNARE complex.
48 entified a first phase (0-2 min) mediated by VAMP2 and second (2-10 min) and third phases (10-30 min)
49 of beta-cells, interact with SNARE proteins VAMP2 and SNAP25, colocalize with insulin granules, and
50 complex with two synaptic vesicle proteins, VAMP2 and synapsin-I, both of which must be phosphorylat
53 ts suggest that the transmembrane domains of VAMP2 and syntaxin 1A contribute to complex assembly and
54 nal fragments of SNAP-25, when combined with VAMP2 and syntaxin 1A, were sufficient for stable comple
58 croscopy confirms both the SNARE identity as VAMP2 and the proteolysis of VAMP2 as a marked decrease
64 this approach, we confirm the requirement of VAMP2 and VAMP7 for insulin and osmotic shock traffickin
67 e, we investigated whether overexpression of VAMP2 and/or VAMP3 could protect insulin-stimulated GLUT
68 with vesicle-associated membrane protein 2 (VAMP2) and plasma membrane proteins syntaxin 1A and syna
70 ysin, vesicle-associated membrane protein 2 (VAMP2), and the vacuolar proton pump as components of th
71 on of syntaxin 1A, the cytoplasmic domain of VAMP2, and amino- and carboxyl-terminal regions of SNAP-
74 18c binding, increased syntaxin 4 binding to VAMP2, and significantly enhanced glucose-stimulated sec
75 ze and coprecipitate with Rab11a, myosin Vb, VAMP2, and syntaxin 4, components of the plasma membrane
78 her, these data demonstrate that syntaxin 4, VAMP2, and/or VAMP3/cellubrevin can function as target m
81 ARE identity as VAMP2 and the proteolysis of VAMP2 as a marked decrease in secondary antibody-conjuga
83 nd SNAP23, and whereas many studies identify VAMP2 as the v-SNARE, others suggest that either VAMP3 o
84 ified vesicle-associated membrane protein 2 (VAMP2) as a critical factor involved in skin differentia
85 ner to facilitate the increase in Syntaxin 4-VAMP2 association and to promote vesicle/granule fusion.
86 wever, no increase in basal level Syntaxin 4-VAMP2 association occurred with either latrunculin treat
89 L348R) within helix 12 selectively abolishes VAMP2 binding and the stimulatory function of Munc18-1 i
91 ed to exhibit glucose-induced activation and VAMP2 binding, and failed to potentiate insulin release
100 of primary cultures of JG cells showed that VAMP2 (but not VAMP3) co-localized with renin-containing
101 of exocytic and endocytic vesicles, such as Vamp2, Clathrin and Dynamin, are sequestered in unreleas
103 ntaining cognate proteins (for instance, the VAMP2 cognate syntaxin1/SNAP-25 complex), the fluorescen
105 hibited formation of the syntaxin 13-SNAP-25-VAMP2 complex by displacing VAMP2 from the complex.
106 and GST-Cdc42-GDP, indicating that the Cdc42-VAMP2 complex could form under both cytosolic GDP-bound
107 induced the dissociation of Cav-1 from Cdc42-VAMP2 complexes, coordinate with the timing of Cdc42 act
108 AMPA receptors requires SNAP25-syntaxin1A/B-VAMP2 complexes, whereas insertion of GABAA receptors re
110 SNARE-dependent liposome fusion assay using VAMP2-containing donor and syntaxin-1/SNAP-25-containing
111 d, tomosyns extensively bind synaptobrevin-2/VAMP2-containing template complexes and prevent SNAP-25
112 The TMD of the SNARE protein synaptobrevin2/VAMP2 contains two highly conserved small amino acids, G
113 ontrast, the R-SNARE protein synaptobrevin-2/VAMP2 contributes to both regulated and constitutive AMP
114 hydrophobic energies by which this domain of VAMP2 could bind to the adjacent lipid bilayer in an ins
116 fuse with vesicles containing synaptobrevin2/VAMP2, demonstrating that syntaxin 3B can function as a
120 demonstrated that insulin stimulates SOCE by VAMP2-dependent Orai1 trafficking to the plasma membrane
123 of its hexamer structure and its binding of VAMP2 dimers, both of which we demonstrate in detergent
124 Here, we investigated nine synaptobrevin-2 (VAMP2) disease-causing variants and uncovered their spec
125 ost identical to vesicle-associated protein (VAMP2-EGFP), and these proteins are often transported to
128 oforms of synaptobrevin, Syb1/VAMP1 and Syb2/VAMP2, exhibit distinct but partially overlapping patter
130 demonstrated that cAMP stimulation enhances VAMP2 exocytosis and promotes VAMP2 interaction with NKC
132 aptic vesicle fusion and Munc18-3:Syntaxin-4:VAMP2 for GLUT4 translocation and insulin release, which
134 , VAMP8, for plasma membrane endocytosis and VAMP2 for sorting to the specialized insulin-responsive
135 ary template complexes - Munc18-1:Syntaxin-1:VAMP2 for synaptic vesicle fusion and Munc18-3:Syntaxin-
137 lipidomic profiling, and further reveal that VAMP2 forms distinctive conformations in different membr
138 mbrane SNAREs syntaxin 1a and SNAP25 bind to VAMP2 found on neurotransmitter-containing vesicles.
140 ealed a parallel redistribution of Cdc42 and VAMP2 from the granule fraction to the plasma membrane i
144 on of syntaxin-4's putative cognate receptor VAMP2 in aquaporin-2-containing vesicles, supports the v
145 riments showed that TeNT efficiently cleaved VAMP2 in depolarized neurons and neurons blocked for syn
146 ings establish a role for both myosin Va and VAMP2 in oligodendrocyte function as it relates to myeli
147 report that NKCC2 co-immunoprecipitates with VAMP2 in rat TALs, and they co-localize in discrete doma
148 protein that is part of a fusion machinery, VAMP2 in the example detailed herein, are included in th
149 eport five heterozygous de novo mutations in VAMP2 in unrelated individuals presenting with a neurode
151 n interacts with the vesicular SNARE protein VAMP2 in vitro and ex vivo (using yeast-2 hybrid and coi
153 reported that a mutation in synaptobrevin 2 (Vamp2) in restless (rlss) mice results in a marked incre
155 induce the targeting of intracellular Cdc42-VAMP2-insulin granule complexes to Syntaxin 1A at the pl
160 Moreover, proteins (Rab3a, syntaxin-1A, and VAMP2) involved in exocytosis also localize with alpha-s
164 at of the ternary SNARE complex, except that VAMP2 is substituted to the second copy of syntaxin 1A.
165 nd VAMP3 are expressed in JG cells, but only VAMP2 is targeted to renin-containing granules and media
166 ecipitation analyses lead us to propose that VAMP2 is the major v-SNARE involved in GLUT4 trafficking
168 revin/vesicle-associated membrane protein 2 (VAMP2) is an essential soluble N-ethyl maleimide-sensiti
169 ce in the interaction between syntaxin 4 and VAMP2, leading to the dysfunction of the SNARE complex.
172 SP-regulated actin dynamics coordinated with VAMP2-mediated exocytosis and involves a novel role for
174 ystem to follow secretion over time revealed VAMP2 mediates an early rapid phase peaking and falling
175 synaptosomal-associated protein 25 (SNAP25), VAMP2 mediates fusion of synaptic vesicles to release ne
178 hin the juxtamembrane domain that reduce the VAMP2 net positive charge, and thus its interaction with
180 NTRK1 in glioblastoma, MSN-ROS1, TRIM4-BRAF, VAMP2-NRG1, TPM3-NTRK1 and RUFY2-RET in lung cancer, FGF
181 with vesicle-associated membrane protein 2 (VAMP2) on GLUT4 storage vesicles (GSVs) and facilitates
183 ir recruitment was sensitive to depletion of VAMP2 or NCS1, whereas recruitment of the recycling endo
186 iomyocytes transiently overexpressing either VAMP2 or VAMP3 were cultured for 16 h with elevated conc
187 te, expression of the cytoplasmic domains of VAMP2 or VAMP3/cellubrevin also resulted in an inhibitio
188 25 (t-SNAREs) and the delivery-vesicle SNARE VAMP2 (or v-SNARE) contain the "SNARE regions" that esse
189 orin on vesicle-associated membrane protein (VAMP2)) or CalipHluorin (pHluorin on an L-type Ca(2+) ch
190 that vesicle-associated membrane protein 2 (VAMP2) orchestrates alphaSYN phase separation both in vi
195 Our results showed that, once internalized, VAMP2-pHluorin/Atto647N-tagged nanobodies exhibited a ma
201 Syntaxin6 and other accessory molecules like VAMP2, Rab6, and Rab8 on Salmonella-containing phagosome
206 describe the dynamic membrane association of VAMP2 SNARE motif in mammalian cells, and the structural
207 markedly weakens the membrane association of VAMP2 SNARE motif, which releases the SNARE motif and fa
209 regulation of different membrane regions on VAMP2 structure and sheds light on the spatial regulatio
210 With the exception of synaptobrevin2, or VAMP2 (syb2), which is directly involved in vesicle fusi
212 rizers." MISTs based on the vesicle proteins VAMP2/Synaptobrevin and Synaptophysin induced rapid ( ap
214 ions with the synaptic vesicle SNARE protein VAMP2/synaptobrevin-2, the synaptic vesicle-attached syn
217 teins synaptobrevin II (sybII, also known as VAMP2), syntaxin, and SNAP-25, generating a force transf
218 sitive attachment protein receptors (SNAREs) VAMP2, Syntaxin-1A, and SNAP-25 in membrane fusion.
219 itive vesicular transport machinery, namely, VAMP2, syntaxin-4, and IRAP, the last of these being the
220 18c depletion ablated the glucose-stimulated VAMP2-Syntaxin 4 association as well as Syntaxin 4 activ
221 mutations confirmed that the Munc18-Syntaxin-VAMP2 "template" complex is a functional intermediate in
222 A mutation in the cytoplasmic domain of VAMP2 that inhibits endocytosis abolished its axonal pol
223 y by activating the synaptic vesicle protein VAMP2 to form SNARE fusion complexes, the molecular mech
224 NARE motif cannot substitute synaptobrevin-2/VAMP2 to form template complexes with Munc18-1 and synta
226 smission by cooperating with synaptobrevin-2/VAMP2 to prevent SNAP-25 binding during SNARE assembly,
227 25, holding them in a conformation ready for VAMP2 to replace it to mediate the membrane fusion event
230 1 and vesicle-associated membrane protein 2 (VAMP2) to form a ternary soluble N-ethylmaleimide-sensit
231 er sequence (e.g., W146C, K174E) alter Kif1a/Vamp2 transport by disrupting Dcx/Kif1a interactions wit
232 ammalian cells, and the structural change of VAMP2 upon the change of intracellular lipid environment
233 to phosphorylated tau (e.g. synaptic protein VAMP2, vacuolar-ATPase subunit ATP6V0D1); therefore, we
234 egulating the endocytosis of SNAREs, such as VAMP2, VAMP3 and VAMP8, which have diverse effects on di
236 fusion factor attachment receptor) proteins VAMP2 (vesicle-associated membrane protein 2) and syntax
237 5 (excitatory amino acid transporter 5), and VAMP2 (vesicle-associated membrane protein 2), are marke
238 additional interaction with synaptobrevin-2/VAMP2 (vesicle-associated membrane protein 2), leading t
239 synaptosome-associated protein of 25 kD) and VAMP2 (vesicle-associated membrane protein 2), precludes
240 idification by live-cell imaging of pHluorin-VAMP2 (vesicle-associated membrane protein-2), a pH-sens
243 tatic interactions, specifically mediated by VAMP2 via its juxtamembrane domain and the alphaSYN C-te
244 rther analysis revealed that the majority of VAMP2 was associated with a distinct class of raft with
248 ricosities, but the vesicular SNARE protein, vamp2, was present in a fraction of those varicosities.
250 Moreover, within these fractions Cdc42 and VAMP2 were found to co-immunoprecipitate under basal and
253 ind a reconstituted integral membrane cargo (VAMP2), which has been covalently linked to mono-ubiquit
254 on of vesicle-associated membrane protein 2 (VAMP2), which is known to associate with myosin Va.
255 esicles containing IRAP, LRP1, sortilin, and VAMP2, which are sequestered by TUG, Ubc9, and other pro
256 singly, application of the soluble domain of VAMP2, which blocks SNARE assembly by competing for bind
257 we show that the R-SNAREs VAMP8, VAMP3, and VAMP2, which cycle between the plasma membrane and endos
260 omplexes of greater thermostability than can VAMP2 with syntaxin 1a and SNAP-25 in vitro, but it lack
262 e fusion protein attachment protein receptor VAMP2 with the target soluble N-ethyl-maleimide-sensitiv
263 e vesicle-associated membrane SNARE protein (VAMP2) with Cdc42 and compared these structural interact